1. A 3D‐Bioprinted Multiple Myeloma Model (Adv. Healthcare Mater. 7/2022). Issue 7 (6th April 2022) Authors: Wu, Di; Wang, Zongyi; Li, Jun; Song, Yan; Perez, Manuel Everardo Mondragon; Wang, Zixuan; Cao, Xia; Cao, Changliang; Maharjan, Sushila; Anderson, Kenneth C.; Chauhan, Dharminder; Zhang, Yu Shrike Other Names: Anseth Kristi S. guestEditor.; Xia Younan guestEditor. Journal: Advanced healthcare materials Issue: Volume 11:Issue 7(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A 3D‐Bioprinted Multiple Myeloma Model. Issue 7 (23rd September 2021) Authors: Wu, Di; Wang, Zongyi; Li, Jun; Song, Yan; Perez, Manuel Everardo Mondragon; Wang, Zixuan; Cao, Xia; Cao, Changliang; Maharjan, Sushila; Anderson, Kenneth C.; Chauhan, Dharminder; Zhang, Yu Shrike Other Names: Anseth Kristi S. guestEditor.; Xia Younan guestEditor. Journal: Advanced healthcare materials Issue: Volume 11:Issue 7(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells. (20th April 2016) Authors: Ray, Arghya; Ravillah, Durgadevi; Das, Deepika S.; Song, Yan; Nordström, Eva; Gullbo, Joachim; Richardson, Paul G.; Chauhan, Dharminder; Anderson, Kenneth C. Journal: British journal of haematology Issue: Volume 174:Number 3(2016) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI‐0052‐107): final study results. (26th October 2017) Authors: Spencer, Andrew; Harrison, Simon; Zonder, Jeffrey; Badros, Ashraf; Laubach, Jacob; Bergin, Krystal; Khot, Amit; Zimmerman, Todd; Chauhan, Dharminder; Levin, Nancy; MacLaren, Ann; Reich, Steven D.; Trikha, Mohit; Richardson, Paul Journal: British journal of haematology Issue: Volume 180:Number 1(2018) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients. (9th May 2016) Authors: Levin, Nancy; Spencer, Andrew; Harrison, Simon J.; Chauhan, Dharminder; Burrows, Francis J.; Anderson, Kenneth C.; Reich, Steven D.; Richardson, Paul G.; Trikha, Mohit Journal: British journal of haematology Issue: Volume 174:Number 5(2016) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study. Issue 5 (May 2020) Authors: Richardson, Paul G; Bringhen, Sara; Voorhees, Peter; Plesner, Torben; Mellqvist, Ulf-Henrik; Reeves, Brandi; Paba-Prada, Claudia; Zubair, Hanan; Byrne, Catriona; Chauhan, Dharminder; Anderson, Kenneth; Nordström, Eva; Harmenberg, Johan; Palumbo, Antonio; Sonneveld, Pieter Journal: Lancet Issue: Volume 7:Issue 5(2020) Page Start: e395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7. Issue 12 (21st December 2017) Authors: Lamberto, Ilaria; Liu, Xiaoxi; Seo, Hyuk-Soo; Schauer, Nathan J.; Iacob, Roxana E.; Hu, Wanyi; Das, Deepika; Mikhailova, Tatiana; Weisberg, Ellen L.; Engen, John R.; Anderson, Kenneth C.; Chauhan, Dharminder; Dhe-Paganon, Sirano; Buhrlage, Sara J. Journal: Cell chemical biology Issue: Volume 24:Issue 12(2017) Page Start: 1490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Synergistic anti‐myeloma activity of the proteasome inhibitor marizomib and the IMiD® immunomodulatory drug pomalidomide. (12th October 2015) Authors: Das, Deepika S.; Ray, Arghya; Song, Yan; Richardson, Paul; Trikha, Mohit; Chauhan, Dharminder; Anderson, Kenneth C. Journal: British journal of haematology Issue: Volume 171:Number 5(2015:Dec.) Page Start: 798 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The power of proteasome inhibition in multiple myeloma. (2nd December 2018) Authors: Guerrero-Garcia, Thomas A.; Gandolfi, Sara; Laubach, Jacob P.; Hideshima, Teru; Chauhan, Dharminder; Mitsiades, Constantine; Anderson, Kenneth C.; Richardson, Paul G. Journal: Expert review of proteomics Issue: Volume 15:Number 12(2018) Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗